newsfilter
← Latest News
GlobeNewswire·

The Lancet Gastroenterology & Hepatology Publishes Data from Albireo's Landmark PEDFIC 1 Study of Bylvay® (odevixibat) Treatment in PFIC

First successful global gold standard pediatric Phase 3 trial ever conducted in cholestatic liver disease PEDFIC 1 & 2 studies were foundational for the approval of Bylvay in the U.S. and Europe Study shows Bylvay provided statistically significant